Citeline Podcasts-logo

Citeline Podcasts

Business & Economics Podcasts

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

Location:

United States

Description:

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

Language:

English


Episodes
Ask host to enable sharing for playback control

Medtech Connect 16: AI For Cross Border Regulation

7/20/2024
In this episode, Medtech Insight senior reporter Hannah Daniel speaks to DJ Fang, chief operating officer and co-founder of Pure Global. Pure Global uses AI to help device manufacturers navigate global regulations, and we talk about clinical trials, how countries incentivize medtech innovation, and the Biden Administration’s tariffs on some Chinese-made medical devices.

Duration:00:19:31

Ask host to enable sharing for playback control

Drug Fix Special: Why The US Approves Most New Drugs Before The EU

7/19/2024
Pink Sheet reporter and editors discuss the impact of a US and EU drug approvals analysis that found the US FDA still clears many novel products first, including most new cell and gene therapies and cancer treatments. More On This Topics From The Pink Sheet Pharma Looks To America First: US FDA Holds Overwhelming Lead Over EMA In Novel Approvals: https://pink.citeline.com/PS154948/Pharma-Looks-To-America-First-US-FDA-Holds-Overwhelming-Lead-Over-EMA-In-Novel-Approvals Getting To Global Is A Hurdle For Cell And Gene Therapies: https://pink.citeline.com/PS154953/Getting-To-Global-Is-A-Hurdle-For-Cell-And-Gene-Therapies New Oncologics Overwhelmingly Approved In US Before EU: https://pink.citeline.com/PS154952/New-Oncologics-Overwhelmingly-Approved-In-US-Before-EU Approval Geography: Novel Agent Landscape Across US And EU: https://pink.citeline.com/PS154950/Approval-Geography-Novel-Agent-Landscape-Across-US-And-EU US FDA Offers Faster Route To Market Than EMA: Details On All 108 Approvals: https://pink.citeline.com/PS154951/US-FDA-Offers-Faster-Route-To-Market-Than-EMA-Details-On-All-108-Approvals

Duration:00:30:31

Ask host to enable sharing for playback control

국내 AI 신약개발, 선진국과 격차 줄이려면? (Korean-language podcast)

7/16/2024
신테카바이오 조해경 사장은 Scrip과의 인터뷰에서 국내 AI 신약 개발 현황을 글로벌 흐름와 비교하고, 국내외 경쟁에서 살아남기 위해 국내업계가 해야 할 일에 대해 이야기했습니다. https://scrip.citeline.com/SC150336/Korea-Looks-To-Close-Gap-In-AI-Drug-Development-Capabilities

Duration:00:03:34

Ask host to enable sharing for playback control

The Importance of Exploring Genetic Potential

7/16/2024
Discover the key considerations critical to the genetic analysis for advanced therapies, including qPCR and dPCR. Don’t miss expert insights from Chandler Walker, Product Manager of Digital PCR Instruments at Thermo Fisher Scientific and Janelle Hart, managing editor at Citeline.

Duration:00:08:29

Ask host to enable sharing for playback control

Scrip's Five Must-Know Things - 16 July 2024

7/15/2024
Audio roundup of selected biopharma industry content from Scrip over the business week ended 12 July 2024. In this episode: Q1’s top 10 drugs; Pfizer’s R&D leadership succession; Lilly bolsters IBD pipeline; first half deal volume up but value down; and EU firms’ China sentiment plummets. https://scrip.citeline.com/SC150587/Quick-Listen-Scrips-Five-MustKnow-Things Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

Duration:00:13:43

Ask host to enable sharing for playback control

EPR Consultant Urges Producers To Start Collecting Packaging Data

7/12/2024
In this episode, HBW chats with Michael Washburn, principal at Washburn Consulting, on how producers of single-use packaging subject to extended producer responsibility laws rolling out in Oregon, Colorado and California next year can tackle the tedious work of collecting data on packaging materials.

Duration:00:16:55

Ask host to enable sharing for playback control

Improving Communication: The Relationship Between Biotech And Biopharma

7/10/2024
Improving Communication: The Relationship Between Biotech And Biopharma by Citeline

Duration:00:20:26

Ask host to enable sharing for playback control

【3分で解説 世界のファーマ】第19回 FDA「密な面談」を企業に呼び掛け (Japanese-language podcast)

7/9/2024
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。 今回取り上げた記事はこちら 「US FDA’s Cell-Gene Therapy Office Head Wants Sponsors To Seek Out Meetings( 邦題意訳:米国FDAの細胞遺伝子治療室長「もっと面談を」企業に求める理由は)」 (英語版) https://pink.citeline.com/PS154749/US-FDAs-Cell-Gene-Therapy-Office-Head-Wants-Sponsors-To-Seek-Out-Meetings ※全文の閲覧には購読(有料)が必要です。 世界の製薬ビジネスメディアScrip(スクリップ)とは? https://www.citeline.com/ja-jp/products-services/commercialization/scrip

Duration:00:03:37

Ask host to enable sharing for playback control

Scrip's Five Must-Know Things - 8 July 2024

7/7/2024
Audio roundup of selected biopharma industry content from Scrip over the business week ended 5 July 2024. In this episode: US approval for Lilly’s Alzheimer's contender; the challenges and rewards of late-stage ADCs; Eisai regains control of ADC from BMS; RSV vaccine developers hit by declining expectations; and an interview with Amgen’s Ian Thompson. https://scrip.citeline.com/SC150550/Quick-Listen-Scrips-Five-MustKnow-Things Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

Duration:00:15:54

Ask host to enable sharing for playback control

Scrip M&A Podcast: A Midyear Review of Biopharma Dealmaking and Expectations of What's Ahead

7/5/2024
Scrip's Joseph Haas, Mandy Jackson and Kevin Grogan discuss the biopharma dealmaking environment as we reach the midpoint of 2024. Haas reviews dealmaking data from the first six months of the year and discusses what experts expect in the months ahead. Jackson and Grogan talk about the industry mood coming out of the annual BIO conference in June and what they heard at the meeting.

Duration:00:48:19

Ask host to enable sharing for playback control

Non-Invasive Solutions: Exploring The Role Of Breath Biopsies In Early Detection

7/5/2024
In this episode of the In Vivo podcast, Billy Boyle, CEO of Owlstone Medical, discusses how his company is developing several breath biopsy products for use by clinicians, biopharma companies and researchers.

Duration:00:25:51

Ask host to enable sharing for playback control

In Vivo Podcast Episode with Stefan Woxström

7/2/2024
In Vivo Podcast Episode with Stefan Woxström by Citeline

Duration:00:27:02

Ask host to enable sharing for playback control

How To Innovate For The Ages, With Bayer’s Reese Fitzpatrick And Rachel Koontz

7/1/2024
Aspirin is celebrating its 125th anniversary this year. To find out what brand owner Bayer Consumer Health is doing to celebrate this occasion, and what it is doing to take the brand into the next 125 years, HBW Insight chats with the company’s senior vice president, Global Head Allergy, Cough/Cold, Pain and Heart Health, Reese Fitzpatrick, and head of R&D, North America and Therapeutics, Rachel Koontz. Already used for a variety conditions by consumers and patients across the world, the Aspirin brand has much more to offer, they argue, for example, in terms of digital self-care, with the firm working with British medtech firm Huma Therapeutics on a Heart Health Risk Assessment app that it currently markets in the US and Middle East. Aspirin also still has Rx-to-OTC switch potential, they reveal, for example in markets like Mexico where the brand is not already available without a prescription. And if that’s not enough, we also discuss Bayer’s extension of the Aspi brand into the naturals space, particularly in the cough and cold category in Europe. Timestamps 2:25 – Introductions 3:30 – Aspirin’s 125th anniversary 5:50 – Aspirin’s brand longevity 14:15 – Challenges of self-care 25:20 – Digital self-care and chronic conditions 27:50 – Aspirin’s Rx-to-OTC switch potential 33:30 – Science and self-care 39:90 – Natural alternatives 44:15 – What’s next for Aspirin?

Duration:00:47:55

Ask host to enable sharing for playback control

Scrip's Five Must-Know Things - 1 July 2024

6/30/2024
Audio roundup of selected biopharma industry content from Scrip over the business week ended 28 June 2024. In this episode: global CEO remuneration; another late-stage loss for Merck KgaA; deals shift to smaller M&A, partnering; Bayer’s Parkinson’s bets bear fruit; and India looks to innovate CAR-T models. https://scrip.citeline.com/SC150517/Quick-Listen-Scrips-Five-MustKnow-Things Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

Duration:00:16:53

Ask host to enable sharing for playback control

Over the Counter: EPR Consultant Urges Producers To Start Collecting Packaging Data

6/29/2024
In this episode, HBW chats with Michael Washburn, principal at Washburn Consulting, on how producers of single-use packaging subject to extended producer responsibility laws rolling out in Oregon, Colorado and California next year can tackle the tedious work of collecting data on packaging materials.

Duration:00:16:55

Ask host to enable sharing for playback control

Drug Fix: What’s In And Out Of US FDA’s Diversity Action Plan Guidance, AI Guidance Also Coming

6/28/2024
Pink Sheet reporter and editors discuss what the FDA included in its long-awaited guidance on clinical trial diversity action plans, along with what was left out (:35), as well as an upcoming guidance on the use of artificial intelligence in regulatory decision-making (27:30). More On These Topics From The Pink Sheet Diversity Action Plans Should Be Brief And Waiver Requests Filed Early, US FDA Says: https://pink.citeline.com/PS154894/Diversity-Action-Plans-Should-Be-Brief-And-Waiver-Requests-Filed-Early-US-FDA-Says Diversity Enrichment: US FDA Guidance Suggests Sponsors May Need To Overenroll Key Groups: https://pink.citeline.com/PS154895/Diversity-Enrichment-US-FDA-Guidance-Suggests-Sponsors-May-Need-To-Overenroll-Key-Groups US FDA Guidance On Artificial Intelligence For Regulatory Decision-Making Expected This Year: https://pink.citeline.com/PS154868/US-FDA-Guidance-On-Artificial-Intelligence-For-Regulatory-Decision-Making-Expected-This-Year

Duration:00:35:29

Ask host to enable sharing for playback control

China Biotech Podcast - 26 June 2024 (Chinese language)

6/26/2024
Guest speaker “Angus” Shipo Xie of Hankun Law joins Brian Yang to discuss new overseas data transfer rules, while Dexter Yan explains China biotechs' Hutchmed, Jiangsu Hengrui and Innovbent Bio’s clinical data readouts at the recent EHA and ADA annual meetings. https://scrip.citeline.com/SC150487/China-Biotech-Podcast-EHAADA Playlist: https://soundcloud.com/citelinesounds/sets/chinese-language-biopharma

Duration:00:26:26

Ask host to enable sharing for playback control

Scrip's Five Must-Know Things - 24 June 2024

6/23/2024
Audio roundup of selected biopharma industry content from Scrip over the business week ended 21 June 2024. In this episode: the outlook for 2025 launches; Merck confident in new pneumococcal vaccine; multiple US setbacks for Japanese firms; Stock Watch on Moderna missteps; and Sun’s North America head talks plans and strategy. https://scrip.citeline.com/SC150476/Quick-Listen-Scrips-Five-MustKnow-Things Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

Duration:00:16:37

Ask host to enable sharing for playback control

Lung Life AI CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic, Lung LB

6/21/2024
In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI’s journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement and compliance with the US FDA Lab Developed Test ruling.

Duration:00:26:24

Ask host to enable sharing for playback control

The Power Of Herbs For Women’s Wellness, With The SABI’s Hilary Metcalfe and Anna Cave-Bigley

6/17/2024
In this episode, HBW Insight chats with women’s health start-up The SABI about the power of herbal medicine for hormonal wellness. “Inspired by a series of painfully honest conversations they had about their hormonal and emotional challenges,” The SABI markets a range of herbal infusions aimed at alleviating some of the impacts of painful periods and hormonal imbalances, such as digestive discomfort, sleep disruption and anxiety. The SABI founders Hilary Metcalfe and Anna Cave-Bigley also reveal the difficulties of being a woman-led, women’s health startup in a male dominated world, especially when it comes to funding and research. We also discuss the importance of getting the message right, both in terms of connecting women to their hormonal health but also distinguishing The SABI from less credible women’s wellness brands. Timestamps: 2:00 Introductions 5:00 The power of herbs 11:45 The challenges of being a women’s health startup 17:30 The demand for natural women’s health products 24:50 Controversies surrounding natural women’s health alternatives 32:45 What’s next for The SABI Biographies Anna Cave-Bigley is CEO at The SABI, leading sales and strategy “with her signature drive and keen insight on everything from motherhood, hormone balance and mental health to strategy, sales and global operations.” From being a founding member of the international practice for a leading London communication consultancy to spearheading international investment initiatives for the British Government, Anna has honed her operational business expertise over 13 years. She is mother to Lorenzo and Alfie, who “inspired her to co-found The SABI after her devastating experience with clinical postpartum depression.” Co-founder Hilary Metcalfe is a Harvard graduate and accomplished business strategist, who dedicated 12 years to impact investment, sustainability, and management consulting before her health intervened. “Conventional medicine offered only a lifetime of medication for chronic migraines and my then-undiagnosed endometriosis. Determined to find a more natural approach, I became a certified holistic nutritionist, product developer and chef, building and selling a successful plant-based food startup in Amsterdam.” During this time Hilary began formulating the remedies and products that would become The SABI’s core collection.

Duration:00:35:21